For fast-growing biotech firms, CFOs with public company experience are increasingly important—and difficult to find. CEOs and boards who rethink where to find that expertise are more often finding the people they need, and finding them faster.
We have seen biotech CEOs and boards meet this challenge by expanding their reach in four ways: considering first-time CFO candidates, looking to adjacent industries for candidates, more effectively tapping their executive and investor ecosystems, and embracing the increasingly robust group of on-demand executives.